Houston biotech firm adds C-suite roles, opens new research lab in TMC By: Houston Business Journal via Business Journals July 28, 2021 at 18:41 PM EDT ImmunoGenesis is focused on developing a pipeline of therapies aimed at tumors that have resisted other immunotherapies. Read More >> Related Stocks: Harbor Disruptive Innovation ETF
